NorthStar signs exclusive radioisotope distribution, marketing agreement with GE Healthcare

A radioactive isotope in the lab.
NorthStar Medical Radioisotopes has signed an exclusive agreement with GE Healthcare Systems to market and distribute Iodine-123 (I-123), a radioisotope used routinely in nuclear medicine, the Beloit-based radiopharmaceutical company announced today. Under the terms of…

Want to Read More?

Paid BizTimes subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.

Become an Insider Now

Already an Insider? Log In

Or click here to purchase a paywall bypass link for this article.

Get our email updates

Brandon covers startups, technology, manufacturing. He previously worked as a general assignment and court reporter for The Freeman in Waukesha. Brandon graduated from UW-Milwaukee’s journalism, advertising and media studies program with an emphasis in journalism. He enjoys live music, playing guitar and loves to hacky sack.

No posts to display